|
|
|
|
A more recent version of this article appeared on February 1, 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 10, 2007
Revised on September 19, 2007
Accepted on November 20, 2007
Department of *Biomolecular Chemistry and
Laboratory of Genetics, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706
Monitoring Editor: Orna Cohen-Fix
Silencing of the mating-type locus HMR in S. cerevisiae requires DNA elements called silencers. To establish HMR silencing the Origin Recognition Complex binds the HMR-E silencer and recruits the Sir1 protein. Sir1 in turn helps establish silencing by stabilizing binding of the other Sir proteins, Sir2–4. However, silencing is semistable even in sir1
cells, indicating that SIR1-independent establishment mechanisms exist. Furthermore, the requirement for SIR1 in silencing a sensitized version of HMR can be bypassed by high-copy expression of FKH1 (FKH1hc), a conserved forkhead transcription factor, or by deletion of the S-phase cyclin CLB5 (clb5
). FKH1hc caused only a modest increase in Fkh1 levels but effectively reestablished Sir2–4 chromatin at HMR as determined by Sir3-directed chromatin immunoprecipitation. In addition, FKH1hc prolonged the cell cycle in a manner distinct from deletion of its close paralog FKH2, and created a cell cycle phenotype more reminiscent to that caused by a clb5
. Unexpectedly, and in contrast to SIR1, both FKH1hc and clb5
established silencing at HMR using the replication origins, ARS1 or ARSH4, as complete substitutes for HMR-E (HMR
E::ARS). HMR
E::ARS1 was a robust origin in CLB5 cells. However, initiation by HMR
E::ARS1 was reduced by clb5
or FKH1hc, while ARS1 at its native locus was unaffected. The CLB5-sensitivity of HMR
E::ARS1 did not result from formation of Sir2–4 chromatin since sir2
did not rescue origin firing in clb5
cells. These and other data supported a model in which FKH1 and CLB5 modulated Sir2–4 chromatin and late-origin firing through opposing regulation of a common pathway.